Stryker entered a definitive agreement to acquire all issued and outstanding shares of Inari Medical's common stock. Stryker ...
Stryker Corp. yesterday closed on its $4.9 billion acquisition of Inari Medical Inc., which is now a wholly owned subsidiary ...
“The acquisition of Inari Medical marks a significant milestone in expanding our interventional endovascular portfolio,” said Kevin Lobo, Chair and Chief Executive Officer, Stryker. “We look forward ...
The Portage, Michigan–based orthopedic and surgical device giant announced last month that it struck a deal to acquire Inari ...
Stryker reported $6.4 billion in sales and $22,595 million in operating profit for the quarter ending December 31, 2024, ...
From leadership updates to FDA clearances, here are five key updates from spine and orthopedic medtech companies since Feb. 12.
A significant recent development was the announcement of Stryker's intent to acquire Inari Medical (TASE:PMCN) for $80 per share in cash, valuing the equity at $4.9 billion. This acquisition is ...
Portage, Michigan, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of Inari Medical ...
Stryker announced that it has completed the acquisition of Inari Medical, Inc., a provider of solutions for venous thromboembo ...
Stryker (SYK) announced that it has completed the acquisition of Inari Medical (NARI), a company that provides innovative solutions for venous thromboembolism, or VTE, clot removal without the use ...